Thrombin
Thrombin is a Na+ -activated allosteric serine protease that catalyzes the formation of thrombus as well as a series of flux-regulating reactions through the coagulation cascade. In response to vascular injury, thrombin is produced through the activation of its inactive precursor, prothrobin, catalyzed by Factor Xa (a trypsin-like proteinase). As a serine protease characterized by the presence of a catalytic triad, thrombin possess a triad of S195-H57-D189 in its active center, which is required for the nucleophilic attack of the target peptide bond. Located “south-west” of the active center is a Na+ -binding site, through which the binding of a sodium ion allosterically modulates the activity of the serine proteinase.
Products for Thrombin
- Cat.No. Product Name Information
-
BCC1313
5-R-RivaroxabanFactor Xa (FXa) inhibitor
-
BCC1421
Bivalirudin TrifluoroacetateReversible thrombin inhibitor
-
BCC1511
Dabigatran etexilate mesylateDirect thrombin inhibitor,anticoagulant,prodrug of dabigatran
-
BCC1512
Dabigatran ethyl esterThrombin activity inhibitor
-
BCC1543
EdoxabanFactor Xa inhibitor
-
BCC1544
Edoxaban tosylateFxa inhibitor
-
BCC1545
Edoxaban tosylate monohydrateOral factor Xa inhibitor
-
BCC1827
OtamixabanDirect factor Xa inhibitors,potent and selective
-
BCC2139
BIBR 953 (Dabigatran, Pradaxa)Thrombin inhibitor,potent,reversible and direct
-
BCC2295
ApixabanFactor Xa inhibitor
-
BCC3738
BIBR-1048Thrombin inhibitor
-
BCC6382
Ximelagatranthrombin inhibitor,orally available